A Randomized, Double-Blind, Placebo-Controlled, Parallel, 24-Week, Phase 2a Study of Topical Pirenzepine (WST-057) or Placebo in Type 2 Diabetic Patients With Peripheral Neuropathy
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2019
Price : $35 *
At a glance
- Drugs Pirenzepine (Primary)
- Indications Diabetic neuropathies
- Focus Adverse reactions; Proof of concept
- Sponsors WinSanTor
- 04 Nov 2019 Status changed from not yet recruiting to recruiting.
- 04 Jul 2019 Status changed from planning to not yet recruiting.
- 04 Jul 2017 New trial record